Table 3.
Association of tobacco with marijuana use with anxiety, major depressive and comorbid symptoms (n=2439; N=274030); The Texas Adolescent Tobacco and Marketing Surveillance study (TATAMS), Spring 2019
| POR (95% CI) | APORa (95% CI) | |||||||
|---|---|---|---|---|---|---|---|---|
| No symptoms | Anxiety symptoms | Major depressive symptoms | Comorbid symptomsb | No symptoms | Anxiety symptoms | Major depressive symptoms | Comorbid symptomsb | |
| Tobacco with marijuana use | ||||||||
| Ever e-cigarette 1 | 1 | 1.19 (0.83-1.72) | 3.62 (1.75-7.52)* | 1.34 (0.9-2.01) | 1 | 1.14 (0.76-1.7) | 3.68 (1.69-8.00)* | 1.19 (0.76-1.84) |
| Current e-cigarette | 1 | 1.26 (0.71-2.23) | 2.93 (1.35-6.32)* | 1.19 1 (0.75-1.88) | 1 | 1.22 (0.66-2.26) | 2.76 (1.28-5.97)* | 1.04 (0.63-1.73) |
| Ever combustible | 1 | 0.96 (0.58-1.60) | 3.75 (1.62-8.71)* | 2.12 (1.42-3.18)* | 1 | 0.89 (0.51-1.55) | 3.99 (1.66-9.58)* | 1.87 (1.17-2.98)* |
| Current combustible | 1 | 1.01 (0.57-1.78) | 1.73 (0.87-3.43) | 1.46 (0.94-2.27) | 1 | 0.92 (0.50-1.69) | 1.60 (0.80-3.23) | 1.21 (0.73-2.01) |
a
Models adjusted for grade, gender, race/ethnicity and SES.
b
Depression/anxiety comorbidity.
*
p<0.05.
POR: prevalence odds ratio. APOR: adjusted prevalence odds ratio.